Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions

In 2016, World Health Organization published new guidelines for the treatment of multiple drug resistant tuberculosis (MDR TB), which stated that minimum duration of treatment was 9 months. In the Russian Federation, it is impossible to use short course 9-month treatment for MDR-TB since clofazimine...

Full description

Saved in:
Bibliographic Details
Main Authors: A. О. Mаryandyshev, A. I. Kulizhskаya, E. S. Khimovа, D. V. Perkhin, O. M. Sveshnikovа, S. E. Presnovа, N. P. Kurochkinа, A. S. Sotnikov, N. A. Leschevа, I. A. Vаsilyevа
Format: Article
Language:Russian
Published: New Terra Publishing House 2019-08-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1308
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850223785299410944
author A. О. Mаryandyshev
A. I. Kulizhskаya
E. S. Khimovа
D. V. Perkhin
O. M. Sveshnikovа
S. E. Presnovа
N. P. Kurochkinа
A. S. Sotnikov
N. A. Leschevа
I. A. Vаsilyevа
author_facet A. О. Mаryandyshev
A. I. Kulizhskаya
E. S. Khimovа
D. V. Perkhin
O. M. Sveshnikovа
S. E. Presnovа
N. P. Kurochkinа
A. S. Sotnikov
N. A. Leschevа
I. A. Vаsilyevа
author_sort A. О. Mаryandyshev
collection DOAJ
description In 2016, World Health Organization published new guidelines for the treatment of multiple drug resistant tuberculosis (MDR TB), which stated that minimum duration of treatment was 9 months. In the Russian Federation, it is impossible to use short course 9-month treatment for MDR-TB since clofazimine is not registered in this country. The objective of the study: to compare efficacy of short course 9-month treatment of MDR-TB and the standard treatment regimen lasting 18-24 months recommended by the Russian Society of Phthisiologists (ROF). Subjects and methods. 180 MDR TB cases notified in 2015, and 179 MDR TB cases notified in 2016 were enrolled into the trial and treated for 18-24 and 12 months. respectively. Chemotherapy regimens included anti-tuberculosis drugs recommended by the ROF. With a 12-month course of treatment, an injectable drug was used for 4 months and discontinued after culture conversion. Results. The efficacy of the short course chemotherapy reached 81% and was not statistically significantly different from the results of the 18-24-month course of treatment. In the patients treated with short course chemotherapy, treatment interruption made 9.5% versus 13.3% in those treated with standard treatment. There were no statistically significant changes in treatment outcomes of both cohorts of MDR-TB patients. Relapses were registered in 6 MDR TB patients from the cohort treated by the standard regimen.
format Article
id doaj-art-12e5b60048f6476b89056829f71e6ef8
institution OA Journals
issn 2075-1230
2542-1506
language Russian
publishDate 2019-08-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-12e5b60048f6476b89056829f71e6ef82025-08-20T02:05:49ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062019-08-0197751010.21292/2075-1230-2019-97-7-5-101308Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod RegionsA. О. Mаryandyshev0A. I. Kulizhskаya1E. S. Khimovа2D. V. Perkhin3O. M. Sveshnikovа4S. E. Presnovа5N. P. Kurochkinа6A. S. Sotnikov7N. A. Leschevа8I. A. Vаsilyevа9Northern State Medical UniversityArkhangelsk Clinical TB Dispensary; Northern State Medical UniversityArkhangelsk Clinical TB Dispensary; Northern State Medical UniversityArkhangelsk Clinical TB DispensaryArkhangelsk Clinical TB DispensaryMurmansk TB DispensaryMurmansk TB DispensaryTB DispensaryTB DispensaryNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesIn 2016, World Health Organization published new guidelines for the treatment of multiple drug resistant tuberculosis (MDR TB), which stated that minimum duration of treatment was 9 months. In the Russian Federation, it is impossible to use short course 9-month treatment for MDR-TB since clofazimine is not registered in this country. The objective of the study: to compare efficacy of short course 9-month treatment of MDR-TB and the standard treatment regimen lasting 18-24 months recommended by the Russian Society of Phthisiologists (ROF). Subjects and methods. 180 MDR TB cases notified in 2015, and 179 MDR TB cases notified in 2016 were enrolled into the trial and treated for 18-24 and 12 months. respectively. Chemotherapy regimens included anti-tuberculosis drugs recommended by the ROF. With a 12-month course of treatment, an injectable drug was used for 4 months and discontinued after culture conversion. Results. The efficacy of the short course chemotherapy reached 81% and was not statistically significantly different from the results of the 18-24-month course of treatment. In the patients treated with short course chemotherapy, treatment interruption made 9.5% versus 13.3% in those treated with standard treatment. There were no statistically significant changes in treatment outcomes of both cohorts of MDR-TB patients. Relapses were registered in 6 MDR TB patients from the cohort treated by the standard regimen.https://www.tibl-journal.com/jour/article/view/1308pulmonary tuberculosismdr tbshort course tuberculosis chemotherapy
spellingShingle A. О. Mаryandyshev
A. I. Kulizhskаya
E. S. Khimovа
D. V. Perkhin
O. M. Sveshnikovа
S. E. Presnovа
N. P. Kurochkinа
A. S. Sotnikov
N. A. Leschevа
I. A. Vаsilyevа
Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
Туберкулез и болезни лёгких
pulmonary tuberculosis
mdr tb
short course tuberculosis chemotherapy
title Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
title_full Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
title_fullStr Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
title_full_unstemmed Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
title_short Short course treatment regimens for multiple drug resistant tuberculosis in Arkhangelsk, Murmansk and Belgorod Regions
title_sort short course treatment regimens for multiple drug resistant tuberculosis in arkhangelsk murmansk and belgorod regions
topic pulmonary tuberculosis
mdr tb
short course tuberculosis chemotherapy
url https://www.tibl-journal.com/jour/article/view/1308
work_keys_str_mv AT aomaryandyshev shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT aikulizhskaya shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT eskhimova shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT dvperkhin shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT omsveshnikova shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT sepresnova shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT npkurochkina shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT assotnikov shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT nalescheva shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions
AT iavasilyeva shortcoursetreatmentregimensformultipledrugresistanttuberculosisinarkhangelskmurmanskandbelgorodregions